Ralph Metson1, Steven D Pletcher, Dennis S Poe. 1. Department of Otology and Laryngology, Harvard Medical School, Boston, MA, USA. ralph_metson@meei.harvard.edu <ralph_metson@meei.harvard.edu>
Abstract
OBJECTIVE: To evaluate microdebrider eustachian tuboplasty for treatment of patients with eustachian tube dysfunction. STUDY DESIGN: A prospective study of 20 patients with eustachian tube dysfunction who underwent microdebrider eustachian tuboplasty (mETP) was performed at an academic medical center. Surgery involved use of a microdebrider to remove hypertrophied mucosa from the posterior eustachian tube cushion. All patients had concurrent sinonasal disease and underwent endoscopic sinus surgery at the time of mETP. RESULTS: There were no surgical complications. Following mETP, subjective symptoms of ear blockage improved in 14 of 20 patients (70%). Mean pure tone average improved by 6 dB (27 dB pre-op vs 21 dB post-op; P = 0.013). Abnormal tympanogram improved in 11 of 17 patients (65%). Failure of the procedure correlated with severity of mucosal disease as measured by both elevated tissue eosinophil count and advanced sinus CT stage (P = 0.018 and P = 0.014, respectively). Mean follow-up was 13 months (range 3-34 months). CONCLUSION: Microdebrider eustachian tuboplasty appears to be a safe procedure for the treatment of eustachian tube dysfunction.
OBJECTIVE: To evaluate microdebrider eustachian tuboplasty for treatment of patients with eustachian tube dysfunction. STUDY DESIGN: A prospective study of 20 patients with eustachian tube dysfunction who underwent microdebrider eustachian tuboplasty (mETP) was performed at an academic medical center. Surgery involved use of a microdebrider to remove hypertrophied mucosa from the posterior eustachian tube cushion. All patients had concurrent sinonasal disease and underwent endoscopic sinus surgery at the time of mETP. RESULTS: There were no surgical complications. Following mETP, subjective symptoms of ear blockage improved in 14 of 20 patients (70%). Mean pure tone average improved by 6 dB (27 dB pre-op vs 21 dB post-op; P = 0.013). Abnormal tympanogram improved in 11 of 17 patients (65%). Failure of the procedure correlated with severity of mucosal disease as measured by both elevated tissue eosinophil count and advanced sinus CT stage (P = 0.018 and P = 0.014, respectively). Mean follow-up was 13 months (range 3-34 months). CONCLUSION: Microdebrider eustachian tuboplasty appears to be a safe procedure for the treatment of eustachian tube dysfunction.
Authors: Carsten V Dalchow; M Loewenthal; N Kappo; F Jenckel; B B Loerincz; R Knecht Journal: Eur Arch Otorhinolaryngol Date: 2015-03-19 Impact factor: 2.503
Authors: Michael H McDonald; Matthew R Hoffman; Lindell R Gentry; Jack J Jiang Journal: Eur Arch Otorhinolaryngol Date: 2011-11-27 Impact factor: 2.503
Authors: J Douglas Swarts; Cuneyt M Alper; Ellen M Mandel; Richard Villardo; William J Doyle Journal: Ann Otol Rhinol Laryngol Date: 2011-04 Impact factor: 1.547